These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8065777

  • 21. Therapeutic recombinant proteins: trends in US approvals 1982 to 2002.
    Reichert JM, Paquette C.
    Curr Opin Mol Ther; 2003 Apr; 5(2):139-47. PubMed ID: 12772503
    [Abstract] [Full Text] [Related]

  • 22. New drug, antibiotic, and biological drug product regulations; accelerated approval--FDA. Final rule.
    Fed Regist; 1992 Dec 11; 57(239):58942-60. PubMed ID: 10123232
    [Abstract] [Full Text] [Related]

  • 23. The year's new drugs and biologics--2006.
    Graul AI, Sorbera LA, Bozzo J, Serradell N, Revel L, Prous JR.
    Drug News Perspect; 2007 Dec 11; 20(1):17-44. PubMed ID: 17332898
    [Abstract] [Full Text] [Related]

  • 24. Are non-prescription medications needed for weight control?
    Bray GA.
    Obesity (Silver Spring); 2008 Mar 11; 16(3):509-14. PubMed ID: 18239604
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Sanofi Pharmaceuticals, Inc., et al.; withdrawal of approval of 21 new drug applications and 62 abbreviated new drug applications--FDA. Notice.
    Fed Regist; 1998 May 12; 63(91):26191-3. PubMed ID: 10179336
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Fixed-Dose Combination Drug Approvals, Patents and Market Exclusivities Compared to Single Active Ingredient Pharmaceuticals.
    Hao J, Rodriguez-Monguio R, Seoane-Vazquez E.
    PLoS One; 2015 May 12; 10(10):e0140708. PubMed ID: 26469277
    [Abstract] [Full Text] [Related]

  • 33. Trends in exploration of therapeutic targets.
    Zheng CJ, Han LY, Yap CW, Xie B, Chen YZ.
    Drug News Perspect; 2005 Mar 12; 18(2):109-27. PubMed ID: 15883620
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic monoclonal antibodies: trends in development and approval in the US.
    Reichert JM.
    Curr Opin Mol Ther; 2002 Apr 12; 4(2):110-8. PubMed ID: 12044031
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The food and drug administration and molecular imaging agents: potential challenges and opportunities.
    Henderson JA, Alexander BC, Smith JJ.
    J Am Coll Radiol; 2005 Oct 12; 2(10):833-40. PubMed ID: 17411943
    [Abstract] [Full Text] [Related]

  • 38. Managing the expanded use of biologics across therapeutic areas: an example from b-cell targeted therapies.
    Cohen M, Morrow T, Penna P.
    Am J Manag Care; 2006 Mar 12; 12(2 Suppl):S24-37; quiz S38. PubMed ID: 16551202
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.